Global /Australia /Healthcare /Drug Manufacturers - Specialty & Generic /EOF
chevron_leftBack
Ecofibre Ltd. logo

Ecofibre Ltd.

EOF
ASX: EOF Delayed
0.0200AUD 0%
0.0143 USD
As of 5 June 2026, Ecofibre Ltd. has a market cap of $5.2M USD, ranking #44347 globally and #1553 in Australia. It ranks #3929 in the Healthcare sector, and #277 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
44347
Country Rank
1553
Sector Rank
3929
Industry Rank
277
Key Stats
Market Cap
$5.2MUSD
7.29M AUD
Revenue (TTM)
$20.25MUSD
28.37M AUD
EBITDA (TTM)
-$9.61MUSD
-13.47M AUD
Net Income (TTM)
-$11.78MUSD
-16.51M AUD
EBITDA Margin
-47%
Profit Margin
-58%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ulrich Tombuelt open_in_new
Founded
2009
Website
ecofibre.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% - -9.1% -17% -52% -67%

News

Loading...

Markets

Exchange Ticker Price
Australian Securities Exchange
MIC: XASX
PRIMARY
EOF
Ecofibre Ltd Ordinary Shares
ISIN: AU0000040057
Shares Out.:
366.629M1 Shares Float: 168.014M2
TV:
SA:
YF:
GF:
BA:
EOF
MS:
0.0200 AUD
OTC Markets
MIC: OTCM
EOFBF
Ecofibre Ltd Ordinary Shares
ISIN: AU0000040057
TV:
SA:
YF:
GF:
BA:
MS:
0.0010 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Ecofibre Ltd.

Ecofibre Limited, together with its subsidiaries, engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia. The company operates through Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, and EOF Bio segments. It offers cannabinoid based health products for human and pet consumption. In addition, the company provides yarn, polymer textiles, and hemp related food products. Further, it is involved in patient-centered cannabinoid-based drug activities. Ecofibre Limited was incorporated in 2009 and is based in Sydney, Australia.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Australia)
Name
Market Cap diff.
PE
$1.11B
1.55B AUD
21K%
52.7
$123.03M
172.39M AUD
2K%
-
$114.37M
160.26M AUD
2K%
18.1
$100.03M
140.17M AUD
2K%
14.1
$56.42M
79.06M AUD
984%
-
BNIGF
$49.41M
850%
-
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.66B
108.92B ILS
724K%
24.2
$29.56B
568K%
-
$15.86B
107.34B CNY
305K%
16.0
CIPLA
$11.12B
1.06T INR
214K%
23.4
LUPIN
$11.0B
1.05T INR
211K%
22.7
$9.1B
61.6B CNY
175K%
80.6
chevron_leftBack